facebook
twitter
rss
account
search
search
 

Personalized warfarin therapy developed

Feb. 26, 2010 at 3:13 PM   |   Comments

COLUMBUS, Ohio, Feb. 26 (UPI) -- U.S. researchers say their new rapid, genotyping method can help clinicians choose appropriate doses of the blood thinner warfarin for individual patients.

Researchers at Ohio State University in Columbus, led by Dr. Haifeng Wu, say their rapid, genotyping method can identify the single nucleotide polymorphisms that affect use of warfarin -- a drug commonly prescribed to prevent blood clots.

Warfarin, also known as Coumadin, needs to be closely monitored because dosing is complicated by interactions with some foods and other drugs, Wu says.

"On-site application of this method in hospital laboratories will greatly help clinicians to determine appropriate doses of warfarin to treat patients with thromboembolic disorders," study authors said in a statement.

The study was published in the Journal of Molecular Diagnostics.

© 2010 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
trending
Celebrity Couples of 2014 [PHOTOS]

Celebrity Couples of 2014 [PHOTOS]

Most Popular
1
Schizophrenia is actually eight disorders, not one disease Schizophrenia is actually eight disorders, not one disease
2
Study: too many kids taking antibiotics Study: too many kids taking antibiotics
3
New industry-baked marijuana PSAs advise moderation New industry-baked marijuana PSAs advise moderation
4
Morning exercise helps calm ADHD symptoms in children Morning exercise helps calm ADHD symptoms in children
5
CDC: painkiller overdose deaths still rising, but not as fast CDC: painkiller overdose deaths still rising, but not as fast
Trending News
Video
x
Feedback